Clinical Trials Directory

Trials / Completed

CompletedNCT06409988

Safe Discharge in Lower Gastrointestinal Bleeding

External Validation of the SHA2PE Score and Its Comparison to the Oakland Score for the Prediction of Safe Discharge in Patients With Lower Gastrointestinal Bleeding

Status
Completed
Phase
Study type
Observational
Enrollment
398 (actual)
Sponsor
Germans Trias i Pujol Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The increasing incidence in lower gastrointestinal bleeding (LGIB) leads to a rise in hospital admission. Many LGBI are self-limiting thus the several scores to identify low risk patients suited to outpatient care have been described. We aim to compare two of this scores (Oakland score and SHA2PE score) in terms of performace to predict "safe discharge" from the emergency department.

Detailed description

The growing incidence of lower gastrointestinal bleeding (LGIB) is leading to a rise in hospital admissions even though most LGIB episodes are self-limiting. The Oakland and SHA2PE scores were designed to identify patients best suited to outpatient care. Our aim is to validate the SHA2PE score and compare both of these scores in terms of predictiveness of safe discharge. We conducted a retrospective observational study of LGIB patients admitted to our hospital between June 2014-June 2019. During this period, data from all LGIB episodes admitted from the ED were collected in an electronic anonymized database created specifically for this study. If any of the principal variables or critical information was missing, the patient was excluded from the study.

Conditions

Interventions

TypeNameDescription
OTHERSafe dischargeThere was no specific intervention, we only aimed to see if those admitted patients could have been safely dicharged from the emergency department.

Timeline

Start date
2014-06-01
Primary completion
2019-06-01
Completion
2020-12-30
First posted
2024-05-10
Last updated
2024-05-10

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06409988. Inclusion in this directory is not an endorsement.